Literature DB >> 9061868

Bright and dark sides of nitric oxide in ischemic brain injury.

C Iadecola1.   

Abstract

There is increasing evidence that nitric oxide (NO), a free radical that can act both as a signaling molecule and a neurotoxin, is involved in the mechanisms of cerebral ischemia. Although early investigations yielded conflicting results, the introduction of more-selective pharmacological tools and the use of molecular approaches for deletion of genes encoding for NO synthase have provided a better understanding of the role of NO in the mechanisms of ischemic brain damage. The evidence reviewed in this article suggests that NO is protective or destructive depending on the stage of evolution of the ischemic process and on the cellular source of NO. Defining the role of NO in cerebral ischemia provides the rationale for new neuroprotective strategies based on modulation of NO production in the post-ischemic brain.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9061868     DOI: 10.1016/s0166-2236(96)10074-6

Source DB:  PubMed          Journal:  Trends Neurosci        ISSN: 0166-2236            Impact factor:   13.837


  169 in total

Review 1.  Potent neuroprotectants linked to bifunctional inhibition.

Authors:  V L Dawson
Journal:  Proc Natl Acad Sci U S A       Date:  1999-09-14       Impact factor: 11.205

2.  Alternative splicing of the C-terminal domain regulates cell surface expression of the NMDA receptor NR1 subunit.

Authors:  S Okabe; A Miwa; H Okado
Journal:  J Neurosci       Date:  1999-09-15       Impact factor: 6.167

3.  On the activation of soluble guanylyl cyclase by nitric oxide.

Authors:  Tomas C Bellamy; John Wood; John Garthwaite
Journal:  Proc Natl Acad Sci U S A       Date:  2001-12-18       Impact factor: 11.205

Review 4.  NO as a signalling molecule in the nervous system.

Authors:  Juan V Esplugues
Journal:  Br J Pharmacol       Date:  2002-03       Impact factor: 8.739

5.  Rapid nontranscriptional activation of endothelial nitric oxide synthase mediates increased cerebral blood flow and stroke protection by corticosteroids.

Authors:  Florian P Limbourg; Zhihong Huang; Jean-Christophe Plumier; Tommaso Simoncini; Masayuki Fujioka; Jan Tuckermann; Günther Schütz; Michael A Moskowitz; James K Liao
Journal:  J Clin Invest       Date:  2002-12       Impact factor: 14.808

6.  Characterisation of a novel class of polyamine-based neuroprotective compounds.

Authors:  Ashley K Pringle; Barclay Morrison; Mark Bradley; Fausto Iannotti; Lars E Sundstrom
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2003-08-06       Impact factor: 3.000

7.  Inhibition of mitochondrial respiration by nitric oxide rapidly stimulates cytoprotective GLUT3-mediated glucose uptake through 5'-AMP-activated protein kinase.

Authors:  Pilar Cidad; Angeles Almeida; Juan P Bolaños
Journal:  Biochem J       Date:  2004-12-15       Impact factor: 3.857

Review 8.  The contribution of L-arginine to the neurotoxicity of recombinant tissue plasminogen activator following cerebral ischemia: a review of rtPA neurotoxicity.

Authors:  George W J Harston; Brad A Sutherland; James Kennedy; Alastair M Buchan
Journal:  J Cereb Blood Flow Metab       Date:  2010-08-25       Impact factor: 6.200

9.  Neuroprotective effects of cactus polysaccharide on oxygen and glucose deprivation induced damage in rat brain slices.

Authors:  Xianju Huang; Qin Li; Yingpei Zhang; Qing Lü; Lianjun Guo; Lin Huang; Zhi He
Journal:  Cell Mol Neurobiol       Date:  2007-08-22       Impact factor: 5.046

10.  L-arginine and Alzheimer's disease.

Authors:  Jing Yi; Laura L Horky; Avi L Friedlich; Ying Shi; Jack T Rogers; Xudong Huang
Journal:  Int J Clin Exp Pathol       Date:  2008-10-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.